Revlimid Maintenance Following Stem Cell Transplant in Multiple Myeloma Patients Appears to Improve Overall Survival
Researchers at Buffalo, New York’s Roswell Park Cancer Institute…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
ASCO 2016: Updated Data of MOR202 for Multiple Myeloma Presented by MorphoSys
In a poster presentation at the 2016 ASCO Annual…
Clinical Results of Selinexor Combo Regimen for Multiple Myeloma Presented by Moffitt Cancer Cancer at ASCO 2016
The Moffitt Cancer Center has completed a Phase 1…
European Commission Approves Janssen’s Multiple Myeloma Treatment Darzalex (Daratumumab)
The European Commission (EC) has granted provisional approval…
New Clinical Trial for Multiple Myeloma Patients to Evaluate Safety and Efficacy of SurVaxM Vaccine
An immune-based vaccine created by researchers at Buffalo, New…
Iceni Planning a Phase 2 Study of Cilengitide in Multiple Myeloma Patients
Iceni Pharmaceuticals, formerly known as Big DNA Ltd.,…
